Key result
Concurrent pericardial disease in patients undergoing transcatheter aortic valve repair was associated with a significantly higher in-hospital mortality rate (12.3% vs 1.9%, p < 0.001).
Why the study?
Pericardial disease is a rare complication of TAVR, but its prevalence, predictors, and outcomes are not well studied.
Does concurrent pericardial disease increase in-hospital mortality and complications in patients undergoing transcatheter aortic valve repair?
Observational (n=218,340)
Yes
Does concurrent pericardial disease increase in-hospital mortality and complications in patients undergoing transcatheter aortic valve repair?
Pericardial disease is a rare but serious complication of TAVR that is associated with significantly increased in-hospital mortality, length of stay, and healthcare costs.
Background Pericardial disease (PD) - acute pericarditis (AP) and pericardial effusion (PE) - is a rare complication of transcatheter aortic valve repair (TAVR) although its prevalence, predictors, and outcomes are not well studied. Methods We used the National Inpatient Sample (NIS) database to find patients who received TAVR between 2011 and 2018. TAVR patients were divided into two groups: with and without PD (AP and/or PE). The baseline characteristics between the two groups were compared using the Chi-square test and student t-test. Variables with a p-value of 0.20 or less from the univariate logistic regression were included in the multivariate logistic regression to find independent predictors of PD in TAVR patients. Results Out of 218,340 TAVR hospitalizations, 4323 (1.2%) had a concurrent diagnosis of PD. TAVR patients with PD were older (81 ± 7 vs 80 ± 6 years, p < 0.05), more likely to be females (62 vs 46%, p < 0.001), white (84.2 vs 82.9%, p = 0.83), and had a higher burden of comorbidities (Table 3). TAVR patients with PD had higher in-hospital mortality rate (12.3 vs 1.9%, p < 0.001), mean length of stay (8.4 vs 5.3 days, p < 0.001), and mean total hospital cost ($283,389 vs $224,544, p < 0.001). Age > 75, female sex, atrial fibrillation (Afib), atrial flutter (Aflutter), peripheral vascular disease (PVD), coagulopathy, cirrhosis, malnutrition, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and pacemaker (PM) implantation were the independent predictors of PD in TAVR patients. Conclusion Older, white females with a higher burden of comorbidities and cardiovascular procedures are at higher risk of pericardial complications of TAVR procedure. Sex-based disparities in the prevalence of PD after TAVR is an area of further research. Careful selection of patients for TAVR is essential to reduce the burden of these complications.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2021) conducted an observational in Transcatheter Aortic Valve Repair (TAVR) (n=218,340). Concurrent pericardial disease (acute pericarditis and/or pericardial effusion) vs. No pericardial disease was evaluated on In-hospital mortality (p=<0.001). Concurrent pericardial disease in patients undergoing transcatheter aortic valve repair was associated with a significantly higher in-hospital mortality rate (12.3% vs 1.9%, p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: